Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Bococizumab Discontinuation Increases Uncertainty For Other PCSK9s

Nov 02 2016

• By Jessica Merrill

Related Content

Pfizer Assembling New Commercial Team For Move Into Dermatology

Oct 19 2016

Pfizer Dashes Hopes For A PCSK9 Pill

Aug 02 2016

PCSK9 Mechanism Lends Confidence Ahead Of Outcomes Data

Mar 23 2015

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Pfizer Inc.

Additional Topics

Research & Development BioPharmaceutical Cardiovascular

More from Cardiovascular

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window